Willis Investment Counsel’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.7M Sell
602,300
-1,700
-0.3% -$76K 1.22% 32
2026
Q1
$29.1M Hold
604,000
1.59% 24
2025
Q4
$29.3M Buy
604,000
+47,300
+8% +$2.34M 1.51% 21
2025
Q3
$26.3M Buy
556,700
+56,500
+11% +$2.73M 1.44% 26
2025
Q2
$24.2M Buy
500,200
+179,600
+56% +$9.18M 1.41% 28
2025
Q1
$17.8M Buy
320,600
+84,900
+36% +$4.6M 1.2% 36
2024
Q4
$11.4M Hold
235,700
0.75% 58
2024
Q3
$13.6M Hold
235,700
0.88% 50
2024
Q2
$11.4M Hold
235,700
0.79% 54
2024
Q1
$11.5M Hold
235,700
0.79% 52
2023
Q4
$11.7M Sell
235,700
-600
-0.3% -$29.3K 0.83% 53
2023
Q3
$12.7M Hold
236,300
0.96% 41
2023
Q2
$12.7M Hold
236,300
0.83% 49
2023
Q1
$12.9M Hold
236,300
0.84% 51
2022
Q4
$11.4M Hold
236,300
0.73% 60
2022
Q3
$8.98M Sell
236,300
-34,900
-13% -$1.56M 0.65% 61
2022
Q2
$13.6M Sell
271,200
-4,400
-2% -$234K 0.83% 52
2022
Q1
$14.1M Sell
275,600
-4,800
-2% -$248K 0.75% 57
2021
Q4
$14M Sell
280,400
-3,900
-1% -$193K 0.74% 57
2021
Q3
$13.7M Hold
284,300
0.78% 51
2021
Q2
$15M Buy
284,300
+6,700
+2% +$350K 0.88% 46
2021
Q1
$13.7M Buy
277,600
+134,300
+94% +$6.45M 0.83% 44
2020
Q4
$6.96M Buy
143,300
+125,300
+696% +$6.18M 0.48% 65
2020
Q3
$903K Sell
18,000
-198,600
-92% -$10.2M 0.08% 95
2020
Q2
$11.1M Sell
216,600
-279,800
-56% -$13.6M 0.86% 47
2020
Q1
$21.7M Sell
496,400
-3,900
-0.8% -$187K 1.8% 18
2019
Q4
$25.1M Sell
500,300
-28,500
-5% -$1.34M 1.62% 32
2019
Q3
$24.5M Buy
528,800
+76,800
+17% +$3.31M 1.64% 28
2019
Q2
$19.6M Buy
452,000
+163,580
+57% +$6.96M 1.32% 39
2019
Q1
$14.9M Sell
288,420
-163,580
-36% -$7.01M 1.03% 47
2018
Q4
$19.6M Sell
452,000
-400
-0.1% -$17.6K 1.46% 23
2018
Q3
$20.2M Buy
452,400
+19,000
+4% +$812K 1.39% 28
2018
Q2
$17.3M Buy
433,400
+36,100
+9% +$1.42M 1.28% 28
2018
Q1
$15.9M Buy
397,300
+372,000
+1,470% +$15.5M 1.23% 35
2017
Q4
$1.09M Buy
25,300
+16,200
+178% +$747K 0.08% 112
2017
Q3
$453K Buy
+9,100
New +$440K 0.03% 116
2017
Q2
Sell
-440,800
Closed -$19.9M 125
2017
Q1
$19.9M Sell
440,800
-10,900
-2% -$462K 1.5% 17
2016
Q4
$18.3M Buy
451,700
+77,600
+21% +$3.06M 1.36% 28
2016
Q3
$14.3M Buy
+374,100
New +$15M 1.14% 38

Other funds holding SNY

Willis Investment Counsel's SNY Position: Q2 2026 in Review

Willis Investment Counsel reduced its Sanofi (SNY) stake by 0.28% in Q2 2026, selling an estimated $76K and leaving 602,300 shares worth $25.7M. The position accounts for 1.22% of the portfolio, ranked #32.

Willis Investment Counsel first reported a position in SNY in Q3 2016 and has held it in 39 quarters since. The position peaked at $29.3M in Q4 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Willis Investment Counsel held 602,300 shares of Sanofi worth $25.7M as of Q2 2026.
  • Willis Investment Counsel sold 1,700 Sanofi shares in Q2 2026, an estimated $76K.
  • Sanofi made up 1.22% of Willis Investment Counsel's portfolio in Q2 2026, its #32 holding.
  • Willis Investment Counsel first reported a position in Sanofi in Q3 2016 and has held it in 39 quarters since.
  • Willis Investment Counsel's Sanofi position peaked at $29.3M in Q4 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Willis Investment Counsel's 13F filing for Q2 2026, filed 3 Aug 2026.